TuHURA Biosciences Files 2024 10-K

Ticker: HURA · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1498382

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

TuHURA Bio (HURA) filed its 2024 10-K. All systems go for pharma prep reporting.

AI Summary

TuHURA Biosciences, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Kintara Therapeutics, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. Its business address is in Tampa, Florida. The filing covers financial information and business operations for the period.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of TuHURA Biosciences' financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, TuHURA Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of TuHURA Biosciences, Inc.?

TuHURA Biosciences, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.

When did TuHURA Biosciences, Inc. file its 10-K report?

TuHURA Biosciences, Inc. filed its 10-K report on March 31, 2025.

What was TuHURA Biosciences, Inc. formerly known as?

TuHURA Biosciences, Inc. was formerly known as Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., and Berry Only Inc.

Where is TuHURA Biosciences, Inc. located?

The company's business and mail address is 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL 33612.

What is the fiscal year end for TuHURA Biosciences, Inc.?

The fiscal year end for TuHURA Biosciences, Inc. is December 31.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing